Life Sciences Research Partners V.Z.W.

Total investments

3

Average round size

9M

Portfolio companies

3

Rounds per year

0.09

Exits

3

Areas of investment
BiotechnologyHealth CareHealth DiagnosticsMedical DeviceMedicalTherapeutics

Summary

Life Sciences Research Partners V.Z.W. is the famous VC, which was founded in 1988.

Deals in the range of 5 - 10 millions dollars are the general things for fund. The fund is constantly included in less than 2 investment rounds annually. The increased amount of exits for fund were in 2015. The high activity for fund was in 2013.

Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most successful fund investment fields, there are Health Care, Medical Device. Among the various public portfolio startups of the fund, we may underline Bone Therapeutics, Celyad The fund has exact preference in a number of founders of portfolio startups.

The overall number of key employees were 1.

The typical case for the fund is to invest in rounds with 3 participants. Despite the Life Sciences Research Partners V.Z.W., startups are often financed by S.R.I.W.. The meaningful sponsors for the fund in investment in the same round are Nausicaa Ventures, Hunza Ventures, Grifols. In the next rounds fund is usually obtained by Hunza Ventures, Grifols.

Show more

Investments analytics

Analytics

Total investments
3
Lead investments
0
Exits
3
Rounds per year
0.09
Investments by industry
  • Biotechnology (3)
  • Health Care (2)
  • Health Diagnostics (1)
  • Medical (1)
  • Therapeutics (1)
  • Show 1 more
Investments by region
  • Belgium (2)
  • United States (1)
Peak activity year
2013

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
13
Group Appearance index
1.00

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Celyad 19 Jan 2009 Biotechnology, Medical Device, Therapeutics Early Stage Venture 8M Belgium, Walloon Brabant
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.